Average Co-Inventor Count = 4.96
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Numab Therapeutics Ag (5 from 12 patents)
2. Namab Therapeutics Ag (1 from 1 patent)
6 patents:
1. 12209133 - Antibodies targeting CD137 and methods of use thereof
2. 12202911 - Multispecific antibody comprising CD137 binding domain and PDL1 binding domain
3. 12098203 - Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA
4. 12077588 - Antibodies targeting PDL1 and methods of use thereof
5. 11578133 - Antibodies targeting CD137 and methods of use thereof
6. 11319371 - Anti-CD3 antibodies